Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Market (the “Nasdaq Stock Market”), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 4 contracts
Samples: Stock Purchase Agreement (Endocardial Solutions Inc), Stock Purchase Agreement (Endocardial Solutions Inc), Stock Purchase Agreement (Endocardial Solutions Inc)
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “"Exchange Act”"), and is listed on the Nasdaq National Market (the “"Nasdaq Stock Market”"), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 3 contracts
Samples: Stock Purchase Agreement (Endocardial Solutions Inc), Stock Purchase Agreement (Endocardial Solutions Inc), Stock Purchase Agreement (Nastech Pharmaceutical Co Inc)
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Market (the “Nasdaq Stock MarketNasdaq”), and the Company has taken no action designed intended to, or which to its actual knowledge is likely to could have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock MarketNasdaq. The issuance of the Shares does Company’s Series B Common Stock is not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rulespublicly traded.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Quantum Fuel Systems Technologies Worldwide Inc), Securities Purchase Agreement (Quantum Fuel Systems Technologies Worldwide Inc), Securities Purchase Agreement (Quantum Fuel Systems Technologies Worldwide Inc)
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Market (the “"Nasdaq Stock Market”"), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares shares does not require shareholder stockholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 3 contracts
Samples: License Agreement (Cell Genesys Inc), License Agreement (Cell Genesys Inc), License Agreement (Transkaryotic Therapies Inc)
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the The Nasdaq National Market (the “"Nasdaq Stock Market”"), and except as set forth on Schedule 2.29, the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the First Closing Shares does not require shareholder stockholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Micro Investment LLC), Securities Purchase Agreement (Micro Therapeutics Inc)
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”"EXCHANGE ACT"), and is listed on the Nasdaq National Market (the “Nasdaq Stock Market”"NASDAQ STOCK MARKET"), and the Company has taken no action designed intended to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace RulesRule 4350(i).
Appears in 2 contracts
Samples: Stock Purchase Agreement (Ats Medical Inc), Stock Purchase Agreement (Vascular Solutions Inc)
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Capital Market (the “Nasdaq Stock Market”), and the Company has taken no action designed intended to, or which to its knowledge is likely to could have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace RulesRule 4350(i).
Appears in 2 contracts
Samples: Securities Purchase Agreement (Prides Capital Partners, LLC), Securities Purchase Agreement (Ediets Com Inc)
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”"EXCHANGE ACT"), and is listed on the Nasdaq National Market (the “Nasdaq Stock Market”"NASDAQ STOCK MARKET"), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Endocardial Solutions Inc), Form of Stock Purchase Agreement (Cyberonics Inc)
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Global Capital Market (along with any trading market or exchange upon which the Common Stock may be listed during any relevant time period under the Agreements, “Nasdaq Stock MarketNasdaq”), and the Company has taken no action designed intended to, or which to its actual knowledge is likely to could have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock MarketNasdaq. The issuance of the Shares does Company’s Series B Common Stock is not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rulespublicly traded.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Quantum Fuel Systems Technologies Worldwide Inc), Securities Purchase Agreement (Quantum Fuel Systems Technologies Worldwide Inc)
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”"EXCHANGE ACT"), and is listed on the Nasdaq National Market (the “Nasdaq Stock Market”"NASDAQ STOCK MARKET"), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares shares does not require shareholder stockholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 1 contract
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “"Exchange Act”"), and is listed on the Nasdaq National Market (the “"Nasdaq Stock Market”"), and the Company has taken no action designed to, or which to its knowledge is reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 1 contract
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “"Exchange Act”"), and is listed on the Nasdaq National Market (the “"Nasdaq Stock Market”"), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 1 contract
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National SmallCap Market (the “Nasdaq Stock SmallCap Market”), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock SmallCap Market. The issuance of the Shares and the Warrant Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace RulesRule 4350(i).
Appears in 1 contract
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National SmallCap Market (the “Nasdaq Stock SmallCap Market”), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock SmallCap Market. The issuance of the Shares Securities does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 1 contract
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Market (the “Nasdaq Stock Market”), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares shares does not require shareholder stockholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 1 contract
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Market (the “Nasdaq Stock Market”), and the Company has taken no action designed intended to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares Securities does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace RulesRule 4350(i).
Appears in 1 contract
Samples: Securities Purchase Agreement (Compex Technologies Inc)
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Market (the “Nasdaq Stock Market”), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 1 contract
Samples: Stock and Warrant Purchase Agreement (Onyx Pharmaceuticals Inc)
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “"Exchange Act”"), and is listed on the Nasdaq National Market (the “"Nasdaq Stock Market”"), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 1 contract
Samples: Stock and Warrant Purchase Agreement (Onyx Pharmaceuticals Inc)
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g12(b) of the Securities Exchange Act of 1934, as amended (the “"Exchange Act”"), and is listed on the Nasdaq National Capital Market (the “Nasdaq Stock Market”"Nasdaq"), and the Company has taken no action designed intended to, or which to its actual knowledge is likely to could have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock MarketNasdaq. The issuance of the Shares does Company's Series B Common Stock is not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rulespublicly traded.
Appears in 1 contract
Samples: Securities Purchase Agreement (Quantum Fuel Systems Technologies Worldwide Inc)
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Market (the “"Nasdaq Stock Market”"), and the Company has taken no action ------------------- designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance Company has received written confirmation from the Nasdaq Stock Market, Inc. that, with respect to the Offering, the Company has satisfied its obligations under the shareholder approval requirements of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Stock Market's Marketplace Rules.
Appears in 1 contract
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”"EXCHANGE ACt"), and is listed on the Nasdaq National Market (the “Nasdaq Stock Market”"NASDAQ STOCK MARKET"), and the Company has taken no action designed to, or which to its knowledge is reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 1 contract
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)amended, and is listed on the Nasdaq National Market (SmallCap Market. The Company currently complies with the “continued listing requirements of the Nasdaq Stock Market”), Marketplace Rules and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock SmallCap Market. The issuance of the Shares does not require shareholder approval, including, including without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 1 contract
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”"EXCHANGE ACT"), and is listed on the Nasdaq National SmallCap Market (the “Nasdaq Stock Market”"NASDAQ STOCK MARKET"), and the Company has taken no action designed intended to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace RulesRule 4350(i).
Appears in 1 contract
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Market (the “Nasdaq Stock Market”), and the Company has taken no action designed to, or which to its knowledge is reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 1 contract
Samples: Stock Purchase Agreement (Act Teleconferencing Inc)
Nasdaq Compliance. The Company’s 's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Market (the “"Nasdaq Stock Market”"), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance Company has received written confirmation from the Nasdaq Stock Market, Inc. that, with respect to the Offering, the Company has satisfied its obligations under the shareholder approval requirements of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Stock Market's Marketplace Rules.
Appears in 1 contract
Samples: Note, Warrant and Unit Purchase Agreement (General Electric Co)
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National SmallCap Market (the “Nasdaq Stock Market”), and the Company has taken no action designed to, or which to its knowledge is reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market. The issuance of the Shares does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules.
Appears in 1 contract
Samples: Stock Purchase Agreement (Avistar Communications Corp)
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the Nasdaq National Capital Market (the “Nasdaq Stock MarketNasdaq”), and the Company has taken no action designed intended to, or which to its actual knowledge is likely to could have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock MarketNasdaq. The issuance of the Shares does Company’s Series B Common Stock is not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rulespublicly traded.
Appears in 1 contract
Samples: Securities Purchase Agreement (Quantum Fuel Systems Technologies Worldwide Inc)
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the The Nasdaq National Global Market (the “Nasdaq Stock Market”), and the Company has taken no action designed intended to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market, nor has the Company received any notification that the SEC or the Nasdaq Stock Market is contemplating terminating such registration or listing. The issuance of the Shares Securities does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace RulesRule 4350(i).
Appears in 1 contract